Enzymatica AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 15.83 million compared to SEK 16.64 million a year ago. Net loss was SEK 14.06 million compared to SEK 22.18 million a year ago. Basic loss per share from continuing operations was SEK 0.09 compared to SEK 0.14 a year ago.
For the full year, sales was SEK 50.9 million compared to SEK 48.95 million a year ago. Net loss was SEK 49.73 million compared to SEK 68.66 million a year ago. Basic loss per share from continuing operations was SEK 0.3 compared to SEK 0.44 a year ago.